Raphael Pharmaceutical (RAPH) Net Shares Issued and Repurchased (2022 - 2025)

Raphael Pharmaceutical has disclosed Net Shares Issued and Repurchased across 4 years of filings, most recently posting $1.0 million for Q4 2025.

• In Q4 2025, Net Shares Issued and Repurchased changed 0.0% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (changed 0.0% YoY), while the FY2025 annual figure was $1.0 million, changed 0.0% from the prior year.
• Net Shares Issued and Repurchased came in at $1.0 million for Q4 2025 at Raphael Pharmaceutical, roughly flat from $1.0 million in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.0 million in Q4 2022 to a low of $1.0 million in Q4 2022.
• Average Net Shares Issued and Repurchased over 4 years is $1.0 million, with a median of $1.0 million recorded in 2022.
• The largest YoY upside for Net Shares Issued and Repurchased was 0.0% in 2023 against a maximum downside of 0.0% in 2023.
• Over 4 years, Net Shares Issued and Repurchased stood at $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1.0 million in Q4 2025, $1.0 million in Q4 2024, and $1.0 million in Q4 2023.